A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury

Files
main.pdf (647.9 KB)
Date
2022
Authors
Memon, Aliza A.
Ahmed, Hasban
Li, Yi
Wongboonsin, Janewit
Hundert, Joshua
Benoit, Stefanie
Chaudhari, Advika
Sher, Jawad
Ghimire, Pratima
Hopkins, Rebecca
Patel, Jay
Stegman, Melinda
Lim, Kenneth
Azzi, Jamil
Siedlecki, Andrew M.
Language
American English
Embargo Lift Date
Department
Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Abstract
Description
Keywords
COVID-19, SARS-CoV2, Acute kidney injury, Hemodialysis, Thrombotic microangiopathy
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Memon AA, Ahmed H, Li Y, et al. A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury. Kidney Int Rep. 2022;7(12):2714-2717. doi:10.1016/j.ekir.2022.09.003
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Kidney International Reports
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/35221
DOI
https://doi.org/10.1016/j.ekir.2022.09.003
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Medicine Works